A federal judge last week reportedly threatened to derail the already-closed $70 billion buyout of health insurer Aetna (NYSE:AET) by CVS Health (NYSE:CVS), saying he felt “kept in the dark, kind of like a mushroom.” At a normally routine hearing last week prior to approving the deal, Judge Richard Leon, of the U.S. District Court for the District of Columbia, […]
ACC ’18 Roundup: Abbott releases long-term HeartMate 3 data
Abbott (NYSE:ABT) touted two-year data yesterday from its trial designed to compare the company’s HeartMate 3 left ventricular assist device to its HeartMate 2 device in patients with advanced heart failure. Data from the study were published in The New England Journal of Medicine and presented at the American College of Cardiology’s 67th Annual Scientific Session. More […]
CVS Health to buy Aetna in $69B merger
CVS Health (NYSE:CVS) plans to buy health insurer Aetna (NYSE:AET) in a $69 billion merger, according to a report from The New York Times. The deal comes as companies like Amazon (NSDQ:AMZN), which is reportedly trying to launch into the pharmacy business, are looking to change the way that consumers interact with the healthcare industry. Get the full story at our sister […]
Boston Scientific logs reimbursement wins
Boston Scientific (NYSE:BSX) yesterday revealed a trifecta of reimbursement wins for its S-ICD subcutaneous defibrillator from the American Medical Assn., Medicare and Aetna.
Diabetes: Medtronic teams up with Aetna to tackle Type II diabetes
NxStage Medical lands Aetna reimbursement win
Health insurance and technology giant Aetna modified its policy on NxStage Medical’s (NSDQ:NXTM) System One home hemodialysis system. dubbing the device "medically necessary" rather than "experimental."
MAKO’s plunge may be good news for buyers | Wall Street Beat
Mako Surgical (NSDQ:MAKO) has had a tough month on Wall Street, with shares having lost 45% since the end of April, but not everyone is running for the hills.
Earlier this week a company director, Frederick Moll, picked up another 5,000 shares at $24.15 each, representing the 1st insider buy on the open market since late last year.
Cordis sues U.S. Patent Office in latest Stent War scrimmage | Legal News
Fewer mergers, but higher valuations, during 2011 | M&A Roundup
About 460 companies were bought for $46.4 billion last year, down 13% from 2010, but the deals were valued 30% higher, compared with the $35.6 billion spent in 2010, according to a Dow Jones VentureSource report.
The median price vaulted 77% to $71 million in 2011. Funding rounds were down 12%, to an average of $17 million raised before exit, reflecting lower start-up costs.
Aetna acquires iTriage app maker Healthagen | Acquisitions Roundup
Aetna Inc. (NYSE: AET) acquired Healthagen, the developer of mobile health app iTriage, for an undisclosed amount. The smartphone app, which lets users check their symptoms, find physicians, book appointments and shop for medical supplies, already has 3 million downloads from iPhone’s App store and the Android market.
The insurance giant plans to integrate iTriage into part of its accountable care organization after it augments the app with some new features.
Gingrich: GOP’s Medicare plan is “right-wing social engineering”
Conservative icon Newt Gingrich, the former speaker of the U.S. House who’s mounting a run at the White House, lambasted a Republican plan to overhaul Medicare over the weekend, calling it "right-wing social engineering.”
Gingrich also voiced his support for the controversial lynch-pin of President Barack Obama’s landmark health care reform law, the so-called individual mandate, which is the object of a slew of constitutional challenges in courts around the country.
MassDevice Network
@MassDevice
LinkedIn
YouTube